Form 20-F CMB.TECH NV For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260421/APBHB22C6222D2C2222F22Z2LBTAZ2228282
Filed on: April 21, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
- Acorn Acquires B Online Learning to Close the Gap Between Learning Investment and Workforce Readiness
- LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
